Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta
The sale is expected to close in the first quarter of 2022
Urban, semi-urban and remote corners of the country will be catered using drone delivery technology
Takes charge to lead business innovation, strategy, alliance & partnerships
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
It plans to add over 1000 employees over the next six months
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
The investment case for health technology in India is frequently overstated in one direction and understated in another
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Subscribe To Our Newsletter & Stay Updated
